Physician profile
Robert W Grant
NPI 1730188574
$539.43
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $510 · 2021: $29.76.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $97.94 | 2019 | |
| Sanofi-Aventis U.S. LLC | $82.40 | 2019 | |
| Amgen INC. | $61.24 | 2019 | |
| Novartis Pharmaceuticals Corporation | $59.41 | 2019 | |
| Corcept Therapeutics | $38.88 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.23 | 2019-2021 | |
| Novo Nordisk INC | $24.49 | 2019 | |
| Amarin Pharma, INC. | $22.72 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.13 | 2019 | |
| Shire North American Group INC | $17.42 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $16.53 | 2019 | |
| Allergan, INC. | $14.51 | 2019 | |
| Boston Scientific Corporation | $14.07 | 2019 | |
| Alexion Pharmaceuticals, INC. | $13.36 | 2019 | |
| Pfizer INC. | $13.36 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $12.74 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Grant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.